{
    "xml": "<topic id=\"PHP8620\" outputclass=\"drug\" rev=\"1.17\" type=\"drug\" namespace=\"/drugs/mivacurium\" basename=\"mivacurium\" title=\"MIVACURIUM\">\n<title>MIVACURIUM</title>\n<body>\r\n<p outputclass=\"interactionsLinks\"> List of individual interactants: <xref format=\"dita\" href=\"#bnf_int_624\" namespace=\"/interactions/list-of-drug-interactions/muscle-relaxants/muscle-relaxants-non-depolarising/mivacurium\">Mivacurium</xref>\n</p>\n<data name=\"vtmid\">108446009</data>\n<data name=\"classifications\">\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_514498464\" title=\"Neuromuscular blocking drugs (non-depolarising)\">Neuromuscular blocking drugs (non-depolarising)</xref>\n</data>\n<data name=\"inheritsFromClass\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClass\" href=\"#PHP34607\" title=\"NON-DEPOLARISING NEUROMUSCULAR BLOCKING DRUGS\" namespace=\"/drug-classes/non-depolarising-neuromuscular-blocking-drugs\">NON-DEPOLARISING NEUROMUSCULAR BLOCKING DRUGS</xref>\n</data>\n</data>\n</data>\n<data name=\"primaryDomainOfEffect\">\n<data name=\"domainOfEffect\">  </data>\n</data>\r\n</body>\n<topic id=\"PHP40120\" outputclass=\"indicationsAndDose\" rev=\"1.30\" parent=\"/drugs/mivacurium\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Neuromuscular blockade (short duration) during surgery and intubation</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">Initially by intravenous injection</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>70&#8211;250&#8239;micrograms/kg; (by intravenous injection) maintenance 100&#8239;micrograms/kg every 15&#8239;minutes, alternatively (by intravenous infusion) maintenance 8&#8211;10&#8239;micrograms/kg/minute, (by intravenous infusion) adjusted in steps of 1&#8239;microgram/kg/minute every 3&#8239;minutes if required; (by intravenous infusion) usual dose 6&#8211;7&#8239;micrograms/kg/minute.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"extremesOfBodyWeight\">\n<title>Doses at extremes of body-weight</title>\n<p>To avoid excessive dosage in obese patients, dose should be calculated on the basis of ideal bodyweight.</p>\n</section>\n</body>\n</topic>\n<topic id=\"PHP52177\" outputclass=\"cautions\" rev=\"1.8\" parent=\"/drugs/mivacurium\">\n<title>Cautions</title>\n<body>\n<section outputclass=\"cautions\">\n<p>\n<ph outputclass=\"caution\">Burns (low plasma cholinesterase activity; dose titration required)</ph>; <ph outputclass=\"caution\">elderly</ph>\n</p>\n</section>\n</body>\n</topic>\n<topic id=\"PHP39710\" outputclass=\"sideEffects\" rev=\"1.14\" parent=\"/drugs/mivacurium\">\n<title>Side-effects</title>\n<body>\n<section outputclass=\"generalSideEffects\">\n<sectiondiv outputclass=\"frequencies\">\n<sectiondiv outputclass=\"veryRare\">\n<p outputclass=\"title\">Very rare</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Anaphylactoid reactions</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"notKnown\">\n<p outputclass=\"title\">Frequency not known</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Bronchospasm</ph>; <ph outputclass=\"sideEffect\">hypotension</ph>; <ph outputclass=\"sideEffect\">skin flushing</ph>; <ph outputclass=\"sideEffect\">tachycardia</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP40193\" outputclass=\"hepaticImpairment\" parent=\"/drugs/mivacurium\">\n<title>Hepatic impairment</title>\n<body>\n<section outputclass=\"doseAdjustments\">\n<sectiondiv>\n<p>Reduce dose in severe impairment.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP39789\" outputclass=\"renalImpairment\" parent=\"/drugs/mivacurium\">\n<title>Renal impairment</title>\n<body>\n<section outputclass=\"doseAdjustments\">\n<sectiondiv>\n<p>Clinical effect prolonged in renal failure&#8212;reduce dose according to response.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP53159\" outputclass=\"directionsForAdministration\" rev=\"1.10\" parent=\"/drugs/mivacurium\">\n<title>Directions for administration</title>\n<body>\n<section>\n<sectiondiv>\n<p>For <i>intravenous infusion</i>, give continuously in Glucose 5% or Sodium chloride 0.9%. Dilute to a concentration of 500&#8239;micrograms/mL; may also be given undiluted. Doses up to 150&#8239;micrograms/kg may be given over 5&#8211;15 seconds, higher doses should be given over 30 seconds. In asthma, cardiovascular disease or in those sensitive to reduced arterial blood pressure, give over 60 seconds.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP8620-medicinalForms\" outputclass=\"medicinalForms\" parent=\"/drugs/mivacurium\">\n<title>Medicinal forms</title>\n<body>\n<section outputclass=\"licensingVariationStatement\">\n<p>There can be variation in the licensing of different medicines containing the same drug.</p>\n</section>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"drugs\" href=\"#drugs\" title=\"Drugs\" namespace=\"/drugs\">Drugs</xref>\n</parents>\n<children>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75866\" title=\"Solution for injection\" namespace=\"/drugs/mivacurium/solution-for-injection\">Solution for injection</xref>\n</children>\n<backlinks>\n<xref format=\"dita\" scope=\"local\" type=\"drugClassifications\" href=\"#PHP106980\" namespace=\"/drug-classifications\" title=\"Drug classifications\" count=\"1\" rel=\"backlink\">Drug classifications</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78426\" namespace=\"/treatment-summaries/neuromuscular-blockade\" title=\"Neuromuscular blockade\" count=\"2\" rel=\"backlink\">Neuromuscular blockade</xref>\n</backlinks>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_624\" namespace=\"/interactions/list-of-drug-interactions/muscle-relaxants/muscle-relaxants-non-depolarising/mivacurium\" title=\"Mivacurium\" count=\"1\" rel=\"link\">Mivacurium</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drugClass\" href=\"#PHP34607\" namespace=\"/drug-classes/non-depolarising-neuromuscular-blocking-drugs\" title=\"NON-DEPOLARISING NEUROMUSCULAR BLOCKING DRUGS\" count=\"1\" rel=\"link\">NON-DEPOLARISING NEUROMUSCULAR BLOCKING DRUGS</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#drugs\" href=\"#drugs\" namespace=\"/drugs\" title=\"Drugs\" count=\"1\" rel=\"link\">Drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75866\" namespace=\"/drugs/mivacurium/solution-for-injection\" title=\"Solution for injection\" count=\"1\" rel=\"link\">Solution for injection</xref>\n</links>\n</topic>",
    "id": "PHP8620",
    "outputclass": "drug",
    "rev": "1.17",
    "type": "drug",
    "namespace": "/drugs/mivacurium",
    "basename": "mivacurium",
    "title": "MIVACURIUM",
    "interactants": [
        {
            "id": "bnf_int_624",
            "label": "Mivacurium"
        }
    ],
    "vtmid": "108446009",
    "drugClassification": [
        "Neuromuscular blocking drugs (non-depolarising)"
    ],
    "inheritsFromClass": [
        "NON-DEPOLARISING NEUROMUSCULAR BLOCKING DRUGS"
    ],
    "primaryDomainOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Neuromuscular blockade (short duration) during surgery and intubation",
                        "html": "Neuromuscular blockade (short duration) during surgery and intubation"
                    }
                ],
                "specificity": {
                    "routes": [
                        "Initially intravenous injection"
                    ],
                    "textContent": "Initially by intravenous injection",
                    "html": "Initially by intravenous injection"
                },
                "adult": [
                    {
                        "textContent": "70&#8211;250 micrograms/kg; (by intravenous injection) maintenance 100 micrograms/kg every 15 minutes, alternatively (by intravenous infusion) maintenance 8&#8211;10 micrograms/kg/minute, (by intravenous infusion) adjusted in steps of 1 microgram/kg/minute every 3 minutes if required; (by intravenous infusion) usual dose 6&#8211;7 micrograms/kg/minute.",
                        "html": "<p>70&#8211;250&#8239;micrograms/kg; (by intravenous injection) maintenance 100&#8239;micrograms/kg every 15&#8239;minutes, alternatively (by intravenous infusion) maintenance 8&#8211;10&#8239;micrograms/kg/minute, (by intravenous infusion) adjusted in steps of 1&#8239;microgram/kg/minute every 3&#8239;minutes if required; (by intravenous infusion) usual dose 6&#8211;7&#8239;micrograms/kg/minute.</p>"
                    }
                ]
            }
        ],
        "extremesOfBodyWeight": [
            {
                "type": "extremesOfBodyWeight",
                "title": "Doses at extremes of body-weight",
                "textContent": "To avoid excessive dosage in obese patients, dose should be calculated on the basis of ideal bodyweight.",
                "html": "<p>To avoid excessive dosage in obese patients, dose should be calculated on the basis of ideal bodyweight.</p>"
            }
        ]
    },
    "cautions": {
        "cautions": [
            {
                "type": "cautions",
                "textContent": "Burns (low plasma cholinesterase activity; dose titration required)",
                "html": "Burns (low plasma cholinesterase activity; dose titration required)"
            },
            {
                "type": "cautions",
                "textContent": "elderly",
                "html": "elderly"
            }
        ]
    },
    "sideEffects": {
        "general": {
            "frequencies": {
                "veryRare": [
                    {
                        "type": "veryRare",
                        "textContent": "Anaphylactoid reactions",
                        "html": "Anaphylactoid reactions",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    }
                ],
                "notKnown": [
                    {
                        "type": "notKnown",
                        "textContent": "Bronchospasm",
                        "html": "Bronchospasm",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "hypotension",
                        "html": "hypotension",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "skin flushing",
                        "html": "skin flushing",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "tachycardia",
                        "html": "tachycardia",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    }
                ]
            }
        }
    },
    "hepaticImpairment": {
        "doseAdjustments": [
            {
                "type": "doseAdjustments",
                "textContent": "Reduce dose in severe impairment.",
                "html": "<p>Reduce dose in severe impairment.</p>"
            }
        ]
    },
    "renalImpairment": {
        "doseAdjustments": [
            {
                "type": "doseAdjustments",
                "textContent": "Clinical effect prolonged in renal failure&#8212;reduce dose according to response.",
                "html": "<p>Clinical effect prolonged in renal failure&#8212;reduce dose according to response.</p>"
            }
        ]
    },
    "directionsForAdministration": {
        "directionsForAdministration": [
            {
                "type": "directionsForAdministration",
                "textContent": "For intravenous infusion, give continuously in Glucose 5% or Sodium chloride 0.9%. Dilute to a concentration of 500 micrograms/mL; may also be given undiluted. Doses up to 150 micrograms/kg may be given over 5&#8211;15 seconds, higher doses should be given over 30 seconds. In asthma, cardiovascular disease or in those sensitive to reduced arterial blood pressure, give over 60 seconds.",
                "html": "<p>For <i>intravenous infusion</i>, give continuously in Glucose 5% or Sodium chloride 0.9%. Dilute to a concentration of 500&#8239;micrograms/mL; may also be given undiluted. Doses up to 150&#8239;micrograms/kg may be given over 5&#8211;15 seconds, higher doses should be given over 30 seconds. In asthma, cardiovascular disease or in those sensitive to reduced arterial blood pressure, give over 60 seconds.</p>"
            }
        ]
    },
    "medicinalForms": {
        "licensingVariationStatement": [
            {
                "type": "licensingVariationStatement",
                "textContent": "There can be variation in the licensing of different medicines containing the same drug.",
                "html": "<p>There can be variation in the licensing of different medicines containing the same drug.</p>"
            }
        ]
    },
    "children": {
        "medicinalForm": [
            {
                "id": "PHP75866",
                "label": "Solution for injection",
                "type": "medicinalForm"
            }
        ]
    },
    "backlinks": {
        "drugClassifications": [
            {
                "id": "PHP106980",
                "label": "Drug classifications",
                "type": "drugClassifications"
            }
        ],
        "treatmentSummary": [
            {
                "id": "PHP78426",
                "label": "Neuromuscular blockade",
                "type": "treatmentSummary"
            }
        ]
    },
    "links": {
        "interaction": [
            {
                "id": "bnf_int_624",
                "label": "Mivacurium",
                "type": "interaction"
            }
        ],
        "drugClass": [
            {
                "id": "PHP34607",
                "label": "NON-DEPOLARISING NEUROMUSCULAR BLOCKING DRUGS",
                "type": "drugClass"
            }
        ],
        "#drugs": [
            {
                "id": "drugs",
                "label": "Drugs",
                "type": "#drugs"
            }
        ],
        "medicinalForm": [
            {
                "id": "PHP75866",
                "label": "Solution for injection",
                "type": "medicinalForm"
            }
        ]
    }
}